Stereoisomerism at the 3-position of glycyrrhetinic acid affects pseudoaldosteronism-related toxicokinetics
Drug Metabolism and Disposition · 2025-11 · 53 (11) · 100180
DOI: 10.1016/j.dmd.2025.100180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025-11. Verfasst von Ryota Sakoda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan. Hauptthemen laut MEDLINE: Glycyrrhetinic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: JST-Mirai Program, Japan Agency for Medical Research and Development, School of Medicine, Keio University.
Abstract (Originalsprache)
Licorice-induced pseudoaldosteronism is attributed to the inhibition of 11β-hydroxysteroid dehydrogenase 2 in renal tubular cells by glycyrrhizic acid metabolites; however, the marked interindividual variability observed in toxic risk remains unclear. In this study, we established stereoselective toxicokinetic profiles for a recently identified metabolite, 3-epi-18β-glycyrrhetinic acid (3-epi-GA), which were compared with the parent compound, 18β-glycyrrhetinic acid (GA). Following a single intravenous administration of these 2 compounds in rats, 3-epi-GA exhibited a 7-fold longer half-life of the elimination phase and a 22-fold higher area under the curve compared with that of GA, based on a noncompartmental analysis. Two-compartment modeling indicated a 13-fold prolongation in the half-life of the elimination phase and an 18-fold increase in area under the curve for 3-epi-GA. The biliary excretion profiles in rats showed distinct differences between the 2 compounds. In rats administered with GA, 18β-glycyrrhetinyl-30-O-glucuronide, GA-3-O-sulfate-30-O-glucuronide (GA3S30G), and 18β-glycyrrhetinyl-3-O-sulfate (GA3S) were detected in the bile. In contrast, rats administered with 3-epi-GA predominantly excreted 3-epi-18β-glycyrrhetinyl-30-O-glucuronide in the bile, whereas 3-epi-GA3S30G and 3-epi-GA3S were present at trace levels. In vitro studies demonstrated that 3-epi-GA was a poor substrate for human sulfotransferase 2A1. Uptake studies revealed that 18β-glycyrrhetinyl-30-O-glucuronide and 3-epi-18β-glycyrrhetinyl-30-O-glucuronide, but not GA or 3-epi-GA, were actively transported into cells by organic anion transporter 3. Both metabolites exhibited strong binding to serum albumin; however, under hypoalbuminemic conditions, the unbound GA fraction was increased, facilitating passive diffusion into renal tubular cells. Collectively, C-3 epimerization of GA significantly attenuated phase II metabolism and biliary excretion, which resulted in prolonged systemic exposure and potential accumulation of 3-epi-GA and its glucuronide compared with GA. These stereochemical differences provide a mechanistic explanation for the marked interindividual variability observed in licorice-induced pseudoaldosteronism and highlight the importance of monitoring 3-epi-GA-derived compounds as potential biomarkers of licorice-related toxicity. SIGNIFICANCE STATEMENT: C-3 epimerization of 18β-glycyrrhetinic acid (GA) by enterobacteria attenuates phase II metabolism and biliary excretion, resulting in prolonged systemic and renal exposure to 3-epi-GA and its glucuronides compared with GA. This provides interindividual variability in GA-related toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
- Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
- Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan. Electronic address: makino@phar.nagoya-cu.ac.jp.
Förderung
- JST-Mirai Program
- Japan Agency for Medical Research and Development
- School of Medicine, Keio University
- Japan Science and Technology Agency
Zitieren
APA
Sakoda, R., Saito, T., Hirasawa, A., Ishiuchi, K., Yasujima, T., Yuasa, H., & Makino, T. (2025). Stereoisomerism at the 3-position of glycyrrhetinic acid affects pseudoaldosteronism-related toxicokinetics. Drug Metabolism and Disposition, 53(11), 100180. https://doi.org/10.1016/j.dmd.2025.100180
Vancouver
Sakoda R, Saito T, Hirasawa A, Ishiuchi K, Yasujima T, Yuasa H, et al. Stereoisomerism at the 3-position of glycyrrhetinic acid affects pseudoaldosteronism-related toxicokinetics. Drug Metabolism and Disposition. 2025;53(11):100180. doi:10.1016/j.dmd.2025.100180
BibTeX
@article{Sakoda2025,
author = {Sakoda, Ryota and Saito, Taikei and Hirasawa, Asuka and Ishiuchi, Kan'ichiro and Yasujima, Tomoya and Yuasa, Hiroaki and Makino, Toshiaki},
title = {Stereoisomerism at the 3-position of glycyrrhetinic acid affects pseudoaldosteronism-related toxicokinetics},
journal = {Drug Metabolism and Disposition},
year = {2025},
volume = {53},
number = {11},
pages = {100180},
doi = {10.1016/j.dmd.2025.100180}
}
EUVIMED